MediSearch ist eine KI-gestützte Suchmaschine, die direkte, wissenschaftlich fundierte Antworten auf medizinische Fragen liefert. Sie synthetisiert Informationen aus zuverlässiger, von Fachleuten geprüfter wissenschaftlicher Literatur und Gesundheitsorganisationen, um vertrauenswürdige und zitierte Gesundheitsinformationen bereitzustellen und komplexe medizinische Forschung für jedermann zugänglich zu machen.
Perplexity ist eine konversationelle KI-Antwortmaschine, die direkte, genaue und zitierte Antworten auf komplexe Fragen liefert. Sie synthetisiert Informationen aus dem Web, um umfassende Antworten mit Quellenlinks zu liefern und revolutioniert so die Art und Weise, wie Benutzer recherchieren, lernen und online Informationen finden.
Produktübersicht
MediSearch Produktübersicht
MediSearch ist eine KI-gestützte Suchmaschine, die direkte, wissenschaftlich fundierte Antworten auf medizinische Fragen liefert. Sie synthetisiert Informationen aus zuverlässiger, von Fachleuten geprüfter wissenschaftlicher Literatur und Gesundheitsorganisationen, um vertrauenswürdige und zitierte Gesundheitsinformationen bereitzustellen und komplexe medizinische Forschung für jedermann zugänglich zu machen.
Perplexity Produktübersicht
Perplexity ist eine konversationelle KI-Antwortmaschine, die direkte, genaue und zitierte Antworten auf komplexe Fragen liefert. Sie synthetisiert Informationen aus dem Web, um umfassende Antworten mit Quellenlinks zu liefern und revolutioniert so die Art und Weise, wie Benutzer recherchieren, lernen und online Informationen finden.
Detailed feature comparison
| Feature | MediSearch | Perplexity |
|---|---|---|
| Hauptkategorie | Medizinische Informationen | Informationsrückgewinnung |
| Hinzugefügt | 2025-08-05 | 2025-08-05 |
| Preismodell | Freemium | Freemium |
| Offizielle Website | medisearch.io | www.perplexity.ai |
| Produkttyp | Website | Website |
| Performance data | ||
| Nutzerbewertung | Nicht verifiziert | Nicht verifiziert |
| Kommentare | 0 | 0 |
| Monatliche Besuche | 234K | 138.1M |
| Monatliches Wachstum | 22.9% | -10.8% |
| Favoriten | 118 | 103 |
| Details | Details ansehen | Details ansehen |
MediSearch vs Perplexity monthly traffic
Compare MediSearch and Perplexity by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
How to interpret the traffic data
In the MediSearch vs Perplexity monthly traffic comparison, MediSearch currently shows 234K visits and Perplexity shows 138.1M; Perplexity has about 590.2 times the visible traffic of MediSearch, an absolute difference of about 137.9M visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
MediSearch is registered at the medisearch.io/zh subpage. Because the current data does not state whether other host pages are excluded, treat this as domain-level context rather than independent traffic for one product or project.
MediSearch monthly traffic:
Latest traffic
Monthly traffic trend
- 2026/1: 121.8K Monatliche Besuche
- 2026/2: 132.8K Monatliche Besuche
- 2026/3: 153.7K Monatliche Besuche
- 2026/4: 190.4K Monatliche Besuche
- 2026/5: 234K Monatliche Besuche
Top-Regionen
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇲🇽Mexico | 30.48% | 71.3K |
| 🇺🇸United States | 29.57% | 69.2K |
| 🇵🇪Peru | 17.7% | 41.4K |
| 🇨🇴Colombia | 11.96% | 28K |
| 🇮🇹Italy | 10.29% | 24.1K |
Traffic-Quellen
| Source type | Percentage | Traffic |
|---|---|---|
| Direkt | 77.25% | 180.8K |
| Verweis | 21.43% | 50.1K |
| 1.32% | 3.1K |
Suchbegriffe
Perplexity monthly traffic:
Latest traffic
Monthly traffic trend
- 2025/9: 169.5M Monatliche Besuche
- 2026/1: 170.1M Monatliche Besuche
- 2026/2: 153.8M Monatliche Besuche
- 2026/3: 166.8M Monatliche Besuche
- 2026/4: 154.9M Monatliche Besuche
- 2026/5: 138.1M Monatliche Besuche
Top-Regionen
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 45.88% | 63.4M |
| 🇮🇳India | 22.86% | 31.6M |
| 🇩🇪Germany | 11.9% | 16.4M |
| 🇷🇺Russia | 10.05% | 13.9M |
| 🇫🇷France | 9.31% | 12.9M |
Traffic-Quellen
| Source type | Percentage | Traffic |
|---|---|---|
| Direkt | 94.18% | 130.1M |
| Verweis | 3.71% | 5.1M |
| 2.11% | 2.9M |
Suchbegriffe
Usage comparison
Compare the core capabilities of MediSearch and Perplexity
MediSearch Core features
Perplexity Core features
Use cases
MediSearch Use cases
Perplexity Use cases
MediSearch vs Perplexity:In-depth comparison and selection guidance
First decide whether the products solve the same kind of need
This in-depth MediSearch vs Perplexity comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. MediSearch is primarily listed under “Medizinische Informationen”, while Perplexity is primarily listed under “Informationsrückgewinnung”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (MediSearch: Medizinische Informationen; Perplexity: Informationsrückgewinnung); Monthly visits (MediSearch: 234K; Perplexity: 138.1M); Monthly growth (MediSearch: 22.9%; Perplexity: -10.8%); Favorites (MediSearch: 118; Perplexity: 103); Website (MediSearch: medisearch.io; Perplexity: www.perplexity.ai). These facts are more useful for selection than brand visibility alone.
What market visibility and monthly traffic mean
In the MediSearch vs Perplexity monthly traffic comparison, MediSearch currently shows 234K visits and Perplexity shows 138.1M; Perplexity has about 590.2 times the visible traffic of MediSearch, an absolute difference of about 137.9M visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
MediSearch is registered at the medisearch.io/zh subpage. Because the current data does not state whether other host pages are excluded, treat this as domain-level context rather than independent traffic for one product or project.
If public market visibility is an important first-pass criterion, investigate Perplexity first. The final choice should still follow taxonomy, use case, and a real trial because higher traffic does not prove broader capabilities or better workflow fit.
Product positioning, use cases, and roles
MediSearch and Perplexity currently overlap in shared categories: Informationsrückgewinnung und Suchmaschine. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
MediSearch's unique categories/tags are Medizinische Informationen, KI-Arzt, evidenzbasiert, Gesundheit, Gesundheitsassistent, Medizinisch, Medizinische Fragen und Forschung; Perplexity's are Inhaltskuration, KI-Chatbot, Antwort-Engine, Zitationsgenerator, Konversations-KI, Informationsrückgewinnung, Wissensentdeckung und Forschungsassistent. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
What ratings, comments, and favorites can tell you
MediSearch has no verified rating, 0 comments, 118 favorites, and 112 likes;Perplexity has no verified rating, 0 comments, 103 favorites, and 80 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Selection guidance by actual need
When to evaluate MediSearch first
Put MediSearch on the priority trial list when the task aligns with “Medizinische Informationen” and especially Medizinische Informationen, KI-Arzt, evidenzbasiert, Gesundheit, Gesundheitsassistent und Medizinisch. This follows recorded positioning and does not imply unlisted capabilities are absent.
MediSearch also currently records: pricing is freemium, product type is website, 234K monthly visits shown for the registered host (subpage scope unknown), no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
When to evaluate Perplexity first
Put Perplexity on the priority trial list when the task aligns with “Informationsrückgewinnung” and especially Inhaltskuration, KI-Chatbot, Antwort-Engine, Zitationsgenerator, Konversations-KI und Informationsrückgewinnung. This follows recorded positioning and does not imply unlisted capabilities are absent.
Perplexity also currently records: pricing is freemium, product type is website, 138.1M verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
How to validate the recommendation before deciding
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in MediSearch and Perplexity, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.




